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Abstract
Aberrant activity of a disintegrin and metalloprotease 17 (ADAM17), also
known as TACE, and epidermal growth factor receptor (EGFR) has been sug-
gested to contribute to chronic obstructive pulmonary disease (COPD) devel-
opment and progression. The aim of this study was to investigate the role of
these proteins in activation of primary bronchial epithelial cells differentiated
at the air–liquid interface (ALI-PBEC) by whole cigarette smoke (CS), com-
paring cells from COPD patients with non-COPD. CS exposure of ALI-PBEC
enhanced ADAM17-mediated shedding of the IL-6 receptor (IL6R) and the
EGFR agonist amphiregulin (AREG) toward the basolateral compartment,
which was more pronounced in cells from COPD patients than in non-COPD
controls. CS transiently increased IL6R and AREG mRNA in ALI-PBEC to a
similar extent in cultures from both groups, suggesting that posttranslational
events determine differential shedding between COPD and non-COPD cul-
tures. We show for the first time by in situ proximity ligation (PLA) that CS
strongly enhances interactions of phosphorylated ADAM17 with AREG and
IL-6R in an intracellular compartment, suggesting that CS-induced intracellu-
lar trafficking events precede shedding to the extracellular compartment. Both
EGFR and ADAM17 activity contribute to CS-induced IL-6R and AREG pro-
tein shedding and to mRNA expression, as demonstrated using selective inhi-
bitors (AG1478 and TMI-2). Our data are consistent with an autocrine-
positive feedback mechanism in which CS triggers shedding of EGFR agonists
evoking EGFR activation, in ADAM17-dependent manner, and subsequently
transduce paracrine signaling toward myeloid cells and connective tissue.
Reducing ADAM17 and EGFR activity could therefore be a therapeutic
approach for the tissue remodeling and inflammation observed in COPD.
Introduction
Chronic obstructive pulmonary disease (COPD) is a pro-
gressive lung disorder characterized by irreversible airflow
obstruction due to airway inflammation, infection, and
tissue remodeling (Vestbo et al. 2013). Airway epithelial
cells play a central role in the pathogenesis of COPD
through a variety of mechanisms, including production of
inflammatory mediators, antimicrobial peptides, and
growth factors (Hiemstra et al. 2015). Exposure of the
lung tissue to triggers like cytotoxic particles and gasses,
including cigarette smoke, microbes, and innate immune
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mediators (Koff et al. 2008; Kim et al. 2011) (Lemjabbar-
Alaoui et al. 2011) (Shao 2004) (Zhou et al. 2012)
activate various matrix metalloproteinases (MMPs) and a
disintegrin and metalloproteinases (ADAMs) expressed by
airway epithelial cells (Dijkstra et al. 2009; Paulissen et al.
2009). The activity of MMPs and ADAMs contributes not
only to proteolytic degradation of lung tissue, but also to
regulation and processing of numerous receptor activating
proteins (Richter et al. 2002; Gomez et al. 2005; Bell et al.
2007; Baumgart et al. 2010). Through these various activi-
ties, MMPs and ADAMs are implicated in a broad spec-
trum of processes ranging from inflammatory responses
to airway epithelial repair. It has been proposed that their
aberrant activity might lead to chronic inflammation and
abnormal tissue remodeling in the lungs of COPD
patients (Paulissen et al. 2009).
One of the ADAMs, a ubiquitously expressed Zn2+-
dependent disintegrin and metalloprotease 17 (ADAM17),
formerly known as TNFa converting enzyme (TACE), is
recognized as an important regulator of pulmonary
inflammation, cell proliferation, and epithelial barrier
function (Gooz 2010; Lemjabbar-Alaoui et al. 2011). In
bronchial epithelial cells, ADAM17 modulates these pro-
cesses by cleaving membrane-bound cytokines (TNFa),
several EGF receptor (EGFR) agonists (TGF-a, amphireg-
ulin, epiregulin, HB-EGF), cytokine receptors (IL6R,
TNF-R), growth factor receptors (NOTCH receptors),
and adhesion proteins (L-selectin, ICAM-1, E-cadherin)
(Gomez et al. 2005; Bell et al. 2007; Baumgart et al. 2010;
Gooz et al. 2012). Moreover, ADAM17 phosphorylation
and activity is enhanced in airway epithelial cell lines and
in undifferentiated primary cells upon exposure to cigar-
ette smoke extract (Lemjabbar et al. 2003; Shao 2004;
Lemjabbar-Alaoui et al. 2011).
Our studies focus on two ADAM17 substrates impli-
cated in COPD pathogenesis: the IL-6 cytokine receptor
(IL6R) and the growth factor amphiregulin (AREG),
one of the EGFR agonists produced by bronchial
epithelial cells (Richter et al. 2002). Elevated levels of
IL6R have been observed in peripheral blood leukocytes
of COPD patients (Edmiston et al. 2010), and recently
genetic variants of IL6R have been linked with COPD
severity (Perez-Rubio et al. 2016). However, the regula-
tion of shedding of IL6R and AREG from COPD air-
way epithelium has not been studied. Upon shedding
from epithelial cells, IL6R and AREG activate the
shared interleukin receptor gp130 and EGFR, respec-
tively, on epithelial cells (autocrine), as well as on
underlying myofibroblasts and myeloid cells (paracrine)
(Burgel and Nadel 2008; Nechemia-Arbely et al. 2008;
Kasina et al. 2009; Rose-John 2012). Both IL6/IL6R/
gp130 and AREG/EGFR/ERK pathways are involved in
the resolution of lung inflammation and repair of
injury, but also in progression of subepithelial fibrosis
and collagen deposition (Zhou et al. 2012). These sig-
naling pathways involve the JAK kinase and/or MAP
kinase pathway, which are druggable targets in COPD
pathology (Barnes 2013). Excessive ligand-mediated
EGFR activation results in epithelial hyperproliferation
and increased production of the inducible mucin
MUC5AC, processes observed in smokers with or with-
out COPD (Lemjabbar et al. 2003; Shao 2004; Desh-
mukh et al. 2005; Kasina et al. 2009; Lemjabbar-Alaoui
et al. 2011; Li et al. 2011; Zhang et al. 2014). Moreover,
EGFR activation results in subsequent transcriptional
regulation of inflammatory mediators such as IL-8
(Richter et al. 2002), a chemokine that has been impli-
cated in COPD development.
So far, studies on the effect of cigarette smoke on
epithelial ADAMs activity has largely relied on the use
of airway epithelial cell lines or undifferentiated primary
cell cultures, stimulated with an aqueous extract of cigar-
ette smoke. However, whole cigarette smoke exposure
and primary differentiated airway cell cultures represent
more relevant physiological conditions. Firstly, fresh
whole cigarette smoke (CS) contains unstable active
components and particulate matter that are largely
absent from extracts. Furthermore, immortalized epithe-
lial cells are poor models of bronchial epithelium in situ,
since they are frequently karyotypically unstable and
heterogeneous, do not show characteristic features of dif-
ferentiation and inherently carry multiple mutations in
pathways essential for growth, differentiation, cell-cell
interaction, and polarization. Furthermore, submerged
cultures of primary airway epithelial cells fail to differen-
tiate. Finally, using cell lines does not allow a compar-
ison of patient populations. Therefore, we examined the
effect of whole CS exposure on shedding of the soluble
interleukin-6 receptor (sIL6R) and the EGFR-ligand
amphiregulin (AREG) by well-differentiated, air–liquid
interface cultured human primary bronchial epithelial
cells (ALI-PBEC).
This allowed us to compare CS-induced ADAM17-
mediated protein shedding and mRNA expression of
sIL6R and AREG in well-differentiated ALI-PBEC from
COPD and non-COPD (ex)smokers. Moreover, we estab-
lished in this model the involvement of both EGFR and
ADAM17 not only in shedding of ADAM17 substrates,
but also in the regulation of mRNA levels of ADAM17
substrates and IL-8. Finally, for the first time, we
observed intracellular CS-induced phosphorylated
ADAM17-substrate interaction via an in situ proximity
ligation assay. Overall, our results provide novel insights
into the activation of airway epithelial cells by cigarette
smoke in COPD, and highlight a possible role of ADAMs
and EGFR in COPD pathology.
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Materials and Methods
Air–liquid interface cell culture of human
primary bronchial epithelial cells
Human airway epithelial cells were obtained from macro-
scopically normal, anonymous bronchial tissue obtained
from lung cancer patients undergoing resection surgery
for lung cancer at LUMC. This material was be used for
research according to the “Code of Conduct for Responsi-
ble Use” (FEDERA code) based on the condition that the
patient has no objection against such use. Primary bron-
chial epithelial cells (PBEC) were isolated from tumor-
free lung resection material (Wetering et al. 2000), and
passage 2 expanded cells were cultured at the air–liquid
interface (ALI) to achieve mucociliary differentiation as
previously described (Amatngalim et al. 2015). Briefly,
40,000 cells were seeded on 0.65 cm Transwell inserts
(Corning Costar, Cambridge, MA) with a 0.4 lm pore
size, which were coated with 30 lg/mL PureCol
(Advanced BioMatrix, San Diego, CA), 10 lg/mL Bovine
serum albumin (Sigma-Aldrich, St. Louis, MO), and
10 lg/mL Fibronectin (isolated from plasma). Cells were
cultured in Bronchial epithelial growth medium (BEGM)
(Lonza, Verviers, Belgium) and Dulbecco’s modified
Eagle’s medium (DMEM) (Gibco, Bleiswijk, The Nether-
lands) (1:1 mixture) containing 1 mmol/L Hepes (Lonza)
and supplemented with SingleQuot supplements and
growth factors according to the manufacturer’s instruc-
tions (bovine pituitary extract, hydrocortisone, human
epidermal growth factor, epinephrine, transferrin, insulin,
T3 and retinoic acid; all from Lonza), additional 15 ng/
mL retinoic acid (Sigma–Aldrich), 1 mg/mL BSA (Sigma–
Aldrich), 100 U/mL penicillin, and 100 lg/mL strepto-
mycin (Lonza). PBEC were initially cultured on inserts in
submerged conditions until cell layers were confluent.
Next, apical medium was removed and cells were cultured
at air-exposed conditions for at least 2 weeks to allow
mucociliary differentiation. Clinical history and lung
function data were obtained from anonymized patients
(Table 1), and COPD disease status was based on lung
function data according to the Global Initiative for
Chronic Obstructive Lung Disease (GOLD) classification
(Vestbo et al. 2013). Donor cells were randomly allocated
to experimental groups.
Cigarette smoke exposure
Air–liquid interface cultured human primary bronchial
epithelial cells were exposed to whole cigarette smoke (CS)
in an exposure model, adapted from (Beisswenger et al.
2004) and previously described in more detail (Amatn-
galim et al. 2015). In this model, ALI-PBEC cultures were
placed in either a CS- or air (negative control) exposure
chamber located in a tissue incubator at 37°C and 5%
CO2. Smoke derived from one cigarette (3R4F reference
cigarettes [University of Kentucky, Lexington, KY]) was
infused into the exposure chamber by a mechanical pump
with a constant flow of 1 L/min, and equally distributed
by a ventilator inside the chamber. After infusion (approx-
imately 4–5 min), residual smoke was removed by infu-
sion of air from the tissue incubator for 10 min. Directly
after CS exposure, the basal medium of the cell cultures
was refreshed and cells were incubated for the indicated
periods of time. Untreated cells used as controls were sub-
jected to the same procedure omitting the smoke (AIR).
Inhibitors
TMI-2 (1 lmol/L; PF-5480090), a highly selective inhibi-
tor of ADAM17 activity (Zhang et al. 2004), was obtained
from Wyeth inc. (Philadelphia, Pennsylvania) and the
selective EGFR inhibitor AG1478 (1 lmol/L) was from
Sigma Aldrich. Cells were preincubated for 1 h with inhi-
bitors before CS exposure, and directly after CS exposure
media were replaced and inhibitors were freshly added.
ELISA
ALI-PBEC conditioned culture media were collected from
the basolateral side of the inserts (1 mL), and apical
washes were obtained by washing the apical surface with
100 lL PBS at different time points, dependent on the
experiment. Collected samples were diluted 1:1 with
BEGM media and analyzed for IL6R and AREG by
human IL6R or AREG ELISA kit, R&D. Further steps
were performed according to the manufacturer’s protocol.
Data were corrected for the dilution factor and insert size,
and the amount of the shed IL6R and AREG was
expressed as pg/mL per cm2.
Table 1. COPD and non-COPD patient characteristics.
COPD non-COPD P-value
Number of donors 15 11
Gender (females/males) 4/11 2/9
Age, years 70  8 66  6 0.1667
FEV1, % predicted 65  16 81  16 <0.01
FEV1/FVC % 55  9 79  9 <0.0001
Characteristics of PBEC donors. Age in years, and lung function as
FEV1 (% predicted) and FEV1/FVC are shown as means  SD. The
mean differences were compared using the nonparametric Mann–
Whitney test. COPD, chronic obstructive pulmonary disease,
FEV1, Forced expiratory volume in one-second, FVC, forced vital
capacity.
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RNA isolation and quantitative real-time
PCR
RNA was isolated using the miRNeasy Mini Kit (Qiagen)
according to the manufacturer’s instructions, and cDNA
was synthesized by reverse-transcription PCR using oligo
(dT) primers (Qiagen) and Moloney murine leukemia
virus (M-MLV) polymerase (Promega, Leiden, The
Netherlands). mRNA expression was determined by quan-
titative real-time PCR as described previously (Amatn-
galim et al. 2015) with primer pairs presented in Table 2.
mRNA expression was quantified using the standard
curve method (Larionov et al. 2005), in which arbitrary
expression levels were normalized to the housekeeping
genes RPL13A and ATP5B. The housekeeping genes were
selected based on stable expression using the “Genorm
method” (Vandesompele et al. 2002).
Proximity ligation assay
Chronic obstructive pulmonary disease ALI-PBEC were-
fixed with 4% paraformaldehyde and permeabilized with
0.5% Triton-X100 in PBS twice for 15 min, blocked with
1% BSA and 0.15% glycine. Next, they were incubated
overnight in 4°C with two different first antibodies simul-
taneously: against ADAM17 (rabbit polyclonal, C-terminal
ADAM17, 25 lg/mL, ab78162, Abcam) or ADAM17PT735
(rabbit polyclonal, phospho-ADAM17 in position T735,
25 lg/mL, ab60996, Abcam) and IL6R (goat anti-human
IL6R recognizing extracellular domain, 20 lg/mL, AF-
227-NA, R&D) or AREG (polyclonal goat anti-human
Areg, 25 lg/mL, AF-262, R&D). All washing steps were
repeated three times with 0.5% Triton-X100 in PBS
(Sigma-Aldrich). Further steps were performed according
to the DuoLink manufacturer’s protocol. Briefly, Proxim-
ity ligation assay (PLA) probes for anti-goat PLUS and
anti-rabbit MINUS were incubated at 37°C for 1 h. Liga-
tion and amplification steps were performed with Detec-
tion Red Reagent. Finally, inserts with ALI-PBEC were
cut out and mounted on the slides with DAPI (Vec-
tashield mounting medium for fluorescence with DAPI,
H-1200). z-stacks were acquired using confocal micro-
scopy (Leica604).
PLA image analysis
The number of dots was counted in the whole z-stack
with Image J software. The threshold values were adjusted
with the Intermodes algorithm (the filter size set between
10 and 437 microns to exclude the small and large dots,
which were in the range of 10% of the total dot count).
The objects on the edges of the culture inserts were
excluded from the analysis. The number of nuclei was
counted in each z-stack by hand to express the number of
dots per nucleus.
Statistical analysis
Data were analyzed with GraphPad Prism Software, using
the appropriate statistical test, as indicated underneath
each figure. Cells from various donors (number indicated
by n in the legends of figures) were used for each experi-
ment, samples were collected from two or three wells
from a single donor, averaged and represented as a single
dot in the figure. Statistical analysis was performed on the
averaged data. Values are presented as mean with SEM
values. Differences at P-values <0.05 were considered to
be statistically significant. ns > 0.05, *P < 0.05,
**P < 0.01, **P < 0.001, ****P < 0.0001.
Results
CS induces shedding of IL6R and AREG by
ALI-PBEC into basolateral medium, but not
apical
We first examined the effect of cigarette smoke (CS)
exposure on the release of sIL6R and AREG by ALI-PBEC
Table 2. Quantitative-PCR primers.
Primer name [ref]
IL8 FW 50-CAGCCTTCCTGATTTCTG-30 Amatngalim et al. (2015)
RV 50-CACTTCTCCACAACCCTCTGC-30
AREG FW 50GTGGTGCTGTCGCTCTTGATA 30 Clarke et al. (2013)
REV 50ACTCACAGGGGAAATCTCACT30
IL6R full-length
form (full-IL6R)
FW 50GCTGTGCTCTTGGTGAGGAAGTTT30 Rath et al. (2010)
REV 50CTGAGCTCAAACCGTAGTCTGTAGAAA30
IL6R alternatively spliced
variant (spliced IL6R)
FW 50GCGACAAGCCTCCCAGGTT30 Rath et al. (2010)
REV 50CCGCAGCTTCCACGTCTTCTT30
FW, Forward primer; REV, Reversed primer.
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at the apical surface and in the basal medium, which con-
tains a maintenance level of EGF, associated with a basal
level of EGFR activity. This was done, using a previously
described whole CS exposure model (Amatngalim et al.
2015), in which CS caused a transient disruption in the
airway epithelial barrier integrity, accompanied by minor
cytotoxic effects measured at the apical surface. Both
sIL6R and AREG were barely detectible in the apical
washes collected from ALI-PBEC of 17 COPD donors at
different stages of disease, following exposure to either CS
or air (Fig. 1A and B). In contrast, sIL6R and AREG were
markedly released into the basal medium in both condi-
tions. CS significantly increased release of sIL6R into the
basal medium at 12 h postexposure, while AREG levels
were increased at 12 and 24 h after CS exposure. These
results demonstrate that shedding of sIL6R and AREG by
ALI-PBEC occurs mainly to the basolateral compartment,
and is enhanced by CS exposure.
CS significantly induces shedding of IL6R
and AREG in COPD ALI-PBEC but not in non-
COPD ALI-PBEC
Next, we explored whether shedding of sIL6R and AREG
differs between ALI-PBEC isolated from COPD patients
and non-COPD (ex)-smokers upon CS and air exposure.
Based on the previous result, the release was only deter-
mined in the basal medium 24 h after exposure. Shedding
of sIL6R and AREG did not differ between COPD and
non-COPD ALI-PBEC exposed to air (Fig. 2A and B),
indicating no differences at baseline conditions. In
contrast, shedding of sIL6R (Fig. 2A) and AREG (Fig. 2B)
was significantly higher after CS exposure only in COPD
ALI-PBEC, and not in non-COPD ALI-PBEC. These data
show that CS-induced release of sIL6R and AREG was
more pronounced in airway epithelial cells from COPD
in comparison to non-COPD donors.
CS-induced IL6R and AREG mRNA expression
is lower in COPD ALI-PBEC compared to non-
COPD cultures
We further determined mRNA expression of IL6R and
AREG in CS and air exposed ALI-PBEC cultures from
COPD and non-COPD patients. The soluble form of
IL6R can be generated either by shedding of the mem-
brane anchored form or by de novo synthesis of the alter-
natively spliced isoform that differs at the C-terminus
(Rose-John 2012). Therefore, we determined mRNA
expression levels of both IL6R variants: the membrane-
anchored (full-IL6R mRNA) and the alternatively spliced
(spliced-IL6R mRNA) variant.
Time-course analysis revealed that CS increased full-
IL6R mRNA 3 h after exposure, but not at later time
points (Fig. 3A). In contrast, baseline expression of
spliced-IL6R mRNA did not differ from the expression
after CS treatment (Fig. 3B), suggesting that the increase
in sIL6R protein levels in culture supernatants did not
result from alternative splicing. Similar to full-IL6R
mRNA, CS significantly induced AREG mRNA expression
3 h after exposure, but not at later time points (Fig. 3C).
These findings suggest that the CS-induced increase in
Figure 1. Cigarette smoke induces shedding of IL6R and AREG by ALI-PBEC into basolateral medium. IL6R (A) and AREG (B) were mainly shed
to the basolateral compartment in ALI-PBEC (COPD donors at different stages, n = 12 for IL6R and n = 5 for AREG). Basolateral media
(basolateral) were collected and apical PBS washes (apical) were performed 12 h and 24 h after CS or air exposure. Both IL6R and AREG were
readily detectable in the basolateral compartment, and barely present in the apical washes. The response of cells from each donor was
analyzed within one experiment using duplicate or triplicate inserts. Statistical analysis was performed by two-way ANOVA (Bonferroni) on the
averaged data from each donor, comparing apical versus basolateral shedding at air and CS exposure, and basolateral shedding at air versus CS
exposure.
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IL6R and AREG shedding is mediated at least in part via
regulation of their mRNA expression levels.
Baseline expression of full-IL6R and AREG mRNA did
not differ between COPD and non-COPD ALI-PBEC
(Fig. 3D and F). After CS exposure, full-IL6R and AREG
mRNA were expressed at higher levels in both non-
COPD and COPD ALI-PBEC. Interestingly, after CS
induction, COPD cells expressed full-ILR and AREG at
lower levels on average but this did not reach statistical
significance (Fig. 3D and F). Spliced-IL6R mRNA expres-
sion did not differ between investigated groups either
after CS or air exposure (Fig. 3E). These findings suggest
that COPD patients may have impaired transcriptional or
posttranscriptional responses to inflammatory and tissue
regenerative triggers. The apparent contrast with the
more pronounced shedding from COPD cells after CS
challenge (Fig. 2) suggests that posttranslational mecha-
nisms determine shedding rate, rather than substrate
mRNA levels.
ADAM17 is required for CS-induced release
of IL6R and AREG in ALI-PBEC
To confirm the previously established involvement of
ADAM17 in the shedding process of IL6R and AREG in
our model, we used the selective ADAM17 inhibitor
TMI-2 (Wyeth) (Zhang et al. 2004). TMI-2 only partially
decreased baseline IL6R release at all investigated time
points (Fig. 4A), plausibly because release of the product
of spliced-IL6R mRNA, which cannot be distinguished
from shed IL-6R with the available antibodies, is not sen-
sitive to inhibitors of ADAMs (Vermes et al. 2012). In
contrast, TMI-2 significantly decreased baseline AREG
shedding at all time points (Fig. 4B). Importantly, CS-
induced shedding of IL6R and AREG was significantly
inhibited by TMI-2 at all time points after CS exposure,
indicating that ADAM17 activity is involved in CS-
induced ADAM17 substrate release (Fig. 4).
ADAM17- and ADAM17P-substrate
interactions are increased after CS exposure
in an intracellular compartment of ALI-PBEC
Next, we explored the interactions of IL6R or AREG with
ADAM17 3 h after CS treatment in ALI-PBEC with an
in situ proximity ligation assay (PLA) (Fredriksson et al.
2002), using antibodies against ADAM17 phosphorylated
at Thr735 (ADAM17-PT735) or total ADAM17. Protein
IL6R/AREG-ADAM17 and IL6R/AREG-ADAM17-PT735
interactions were visualized as fluorescent red dots in x-y
confocal sections (representative confocal pictures shown
in Fig. 5A and B). In air-exposed cells, PLA signals were
largely confined to the basal region, as in the control
incubations, and not significantly higher than background
(data not shown), as indicated by red lines in Figure 5C–
F (relevant control data are shown in Figure S1). Interest-
ingly, CS exposure significantly increased the total num-
ber of PLA signals for interactions of IL6R or AREG with
ADAM17 (Fig. 5C and E). We observed that CS strongly
enhanced interactions of IL6R or AREG with ADAM17-
PT735 (Fig. 5D and F), which further extends previous
findings showing that ADAM17 is phosphorylated after
smoke extract (CSE) exposure in submerged immortalized
NCI-H292 cells (Lemjabbar-Alaoui et al. 2011). CS-
induced PLA signals of substrate-ADAM17 and substrate-
ADAM17-PT735 were primarily detected in the apical
Figure 2. Cigarette smoke significantly induces shedding of IL6R and AREG into basolateral medium by COPD ALI-PBEC. Soluble forms of IL6R
(A) and AREG (B) shed into the basolateral compartment were detected 24 h after CS or air exposure in ALI-PBEC derived from non-COPD and
COPD donors (Table 1). (A) IL6R levels were significantly increased 24 h after CS treatment in COPD-ALI-PBEC (n = 15), but this increase was
not significant in the non-COPD group (n = 11 donors). (B) Similarly, CS exposure significantly increased AREG levels in ALI-PBEC cells derived
from COPD donors (n = 10), but not in non-COPD ALI-PBEC (n = 8 donors). Statistical analysis: paired t-test. n refers to the number of donors,
duplicate or triplicate data were averaged per donor. Statistical analysis was performed on the averaged data from each donor.
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region of the cells and were not confined to a lateral
membrane pattern suggesting an intracellular vesicular
localization of protein complexes in ALI-PBEC. These
data for the first time demonstrate that CS exposure
strongly increases the interaction of ADAM17 and
ADAM17-PT735 with IL6R or AREG in an intracellular
vesicular compartment of ALI-PBEC, suggesting a CS
induced effect on protein trafficking.
Figure 3. CS exposure transiently enhances IL6R and AREG mRNA expression in COPD and non-COPD ALI-PBEC. mRNA levels of the IL6R full-
length variant (full-IL6R) (A), the IL6R splice variant (spliced-IL6R) (B) and AREG (C) were determined by qPCR 3, 12, and 24 h after CS (black
bars) or air exposure (open bars) (n = 14 unspecified donors). A transient induction of full-IL6R (A) and AREG (C), but not spliced-IL6R (B) was
observed at 3 h after CS exposure. In COPD (n = 7) and non-COPD (n = 8) ALI-PBEC, mRNA of full-IL6R (D), spliced-IL6R (E), and AREG (F)
were determined 3 h after CS exposure. mRNA expression of full-IL6R and AREG, was lower on average but not statistically significant in COPD
compared to non-COPD donors. Data were normalized for expression against two reference genes (ATP5B and RPL13A). n refers to the
number of donors. The response of cells from each donor was analyzed within one experiment using duplicate inserts and data were averaged
per donor. Statistical analysis was performed on the averaged data from each donor. Statistical analysis: Two-way ANOVA With Tukey’s
multiple comparison test.
Figure 4. ADAM17 is involved in the release of soluble IL6R and AREG in ALI-PBEC. The selective ADAM17 inhibitor, TMI-2 (Zhang et al. 2004)
decreases basal and CS-induced IL6R (A,B) and AREG (C,D) shedding in ALI-PBEC cells (n = 3 COPD donors) at 3, 6 (A,C), 12, and 24 h time
points (B,D). n refers to the number of donors. The response of cells from each donor was analyzed within one experiment using duplicate or
triplicate inserts and data were averaged per donor. Statistical analysis was performed on the averaged data from each donor, by two-way
ANOVA (Bonferroni), confirming first the effect of CS on IL6R and AREG shedding at different time points, and second the effect of TMI-2 on
shedding during air and CS exposure.
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EGFR is required for basal and induced
AREG shedding in ALI-PBEC
ADAM17-dependent shedding of EGFR ligands such as
AREG results in activation of EGFR through an autocrine
feedback loop, which modulates basal EGFR activity
(DeWitt et al. 2001). This mechanism was shown to be
activated by CS extract in submerged cultured PBEC and
in cell lines (Lemjabbar et al. 2003). In our experimental
set-up, we have previously shown that CS enhances basal
EGFR activity by increasing its phosphorylation (Amatn-
galim et al. 2015). To illustrate the involvement of EGFR
in CS-induced ADAM17-related shedding in ALI-PBEC,
we assessed sIL6R and AREG shedding after starvation for
A
B
C D E F
Figure 5. CS increases substrate-ADAM17 and substrate-ADAM17-PT735 interactions in pseudostratified COPD ALI-PBEC cells. The proximity
ligation assay (PLA) signal in COPD- ALI-PBEC exposed to CS or air was performed for the following interactions: IL6R-ADAM17, IL6R-
ADAM17PT735, AREG-ADAM17, and AREG-ADAM17-PT735. Relevant control data are shown in Figure S1. Here, we show a representative
figure of IL6R-ADAM17PT735 3 h after air (A) and CS exposure (B). Left panels show merged signals of nuclei (blue) and PLA (red) in the x–y
sections of the confocal z-stack and right panel presents PLA signal in the apical region (red dots). The number of PLA interactions was counted
for all interactions as described in the methods section and expressed per nucleus 3 h after CS or air exposure in the whole z-stack of the ALI-
PBEC (C–F). The red lines on the graphs indicate the maximal dot count in the PLA assay controls, in which one of the antibodies for the
interaction was omitted (background staining not shown). For each interaction, cells from one donor were analyzed. Different filters (n = 4)
were used to show distinct interactions. Statistical analysis: unpaired t-test.
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growth factors, using medium devoid of EGF and bovine
pituitary extract (BPE). Removing these factors from the
medium substantially reduced baseline shedding of IL6R
and AREG (Fig. 6), when compared to standard culture
conditions including EGF and BPE (Fig. 4A and C). Both
sIL6R and AREG release were significantly increased at 3 h
after CS exposure. The selective ADAM17 inhibitor TMI-2
and the EGFR tyrosine kinase inhibitor (AG1478) added
prior to CS exposure, partially inhibited sIL6R shedding,
consistent with a substantial contribution of the ADAM-
insensitive splice variant sIL-6R levels in the basal medium
(Fig. 6A). AG1478 strongly impaired AREG shedding, to a
similar extent as TMI-2 (Fig. 6B). These findings together
demonstrate a critical role of EGFR activation in ADAM17-
mediated basal and CS-induced shedding activity.
EGFR and ADAM17 are required for CS-
induced IL6R and AREG mRNA expression
We previously observed that EGFR activation is involved in
CS-induced expression of several genes in ALI-PBEC
(Amatngalim et al. 2015). The molecular mechanism by
which CS activates EGFR are not known. Here, we explored
the effect of ADAM17 and EGFR inhibition on CS-induced
IL6R and AREG mRNA levels in ALI-PBEC. At 3 hours
after CS exposure in the absence of EGF in the medium,
both TMI-2 and AG1478 significantly impaired CS-induced
expression of full-L6R mRNA (Fig. 7A), but not the splice
variant (Fig. 7B). Both inhibitors strongly diminished CS-
induced AREG mRNA levels (Fig. 7C) as well as IL-8
Figure 6. IL6R and AREG shedding depends on ADAM17 and
EGFR activity in COPD-ALI-PBEC. COPD ALI-PBEC (n = 3 donors)
were starved for growth factors for 48 h prior to CS or air
exposure. Three hours after CS exposure, IL6R (A) and AREG (B)
shedding were significantly increased compared to air. The
ADAM17 inhibitor (1 lmol/L TMI-2) and the EGFR inhibitor
(1 lmol/L AG1478) significantly reduced AREG, but IL6R shedding
to a lesser extent. The response of cells from each donor was
analyzed within one experiment using triplicate inserts and data
were averaged per donor. Statistical analysis was performed on the
averaged data from each donor by one way ANOVA (Tukey
multiple comparison test), only relevant comparisons are shown, air
versus CS-treated cells and the effect of inhibitors in CS-treated
cells.
Figure 7. IL6R and AREG mRNA expression are regulated by
ADAM17 and EGFR activity in ALI-PBEC. ALI-PBEC (n = 3 donors)
were starved for growth factors for 48 h prior to CS exposure. At
3 h, CS-induced mRNA levels of full-length IL6R (A), AREG (C), and
IL8 (D) were diminished upon ADAM17 (1 lmol/L TMI-2) and EGFR
(1 lmol/L AG1478) inhibition, whereas that of the alternatively
spliced form of IL6R was not affected (B). n refers to the number of
donors. The response of cells from each donor was analyzed within
one experiment using triplicate inserts and data were averaged per
donor. Statistical analysis was performed on the averaged data
from each donor, by one-way ANOVA (Tukey multiple comparison
test), only relevant comparisons are shown, air versus CS-treated
cells and the effect of inhibitors in CS-treated cells.
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mRNA expression (Fig. 7D). Overall, these findings for the
first time demonstrate that ADAM17, next to EGFR, is
essential in the CS-induced mechanism regulating not only
the mRNA of ADAM17 substrates (IL6R and AREG), but
also IL-8 in ALI-PBEC.
Discussion
Many studies have demonstrated that airway epithelial cells
are activated by exposure to environmental triggers like
cigarette smoke, which contributes to COPD pathology
(Rusznak et al. 2000; Schulz et al. 2004; Heijink et al.
2012; Amatngalim et al. 2015). In contrast to most studies,
we used fresh whole cigarette smoke instead of (aged)
cigarette smoke extract, and ALI-differentiated PBEC from
COPD and non-COPD donors instead of submerged cul-
tures of nondifferentiated primary cells or cell lines.
While the obvious advantage of this approach is that we
can study well-differentiated primary cells from different
patient populations, a limitation is that confirmation of
data obtained with experimental pharmaceutics by, for
example, gene editing or RNAi technology is not feasible in
this context. Aside from efficiency issues and off-target
effects in primary cells, knocking down EGFR or ADAM17
likely affects the growth and differentiation of primary
bronchial epithelial cells, which essentially defeats our pur-
pose. However, the two inhibitors that we apply here to
inhibit EGFR (AG1478) and ADAM17 (TMI-2), respec-
tively are widely used and are known to be highly selective.
Importantly, our data demonstrate for the first time that
CS triggered increase of basal shedding of IL6R and AREG
into the basal medium, in the presence of EGF in the
growth medium providing basal EGFR activity, was more
pronounced in ALI-PBEC derived from COPD patients
compared to non-COPD controls. We further report the
ability of CS to increase mRNA expression of these genes in
an EGFR- and ADAM17-dependent way in ALI-PBEC cells,
under these conditions, with a lower tendency to induction
in the COPD group. These results extend previous studies
showing dysregulated responses of COPD airway epithelial
cells to cellular stress, and provide novel evidence for the
mechanism of CS-induced and COPD-related proinflam-
matory and profibrotic responses (Fig. 8).
The differential effect of CS on sIL6R and AREG
release between COPD and non-COPD ALI-PBEC might
be related to differences in epithelial barrier function as
previously described (Heijink et al. 2014). Using the cur-
rent CS exposure system, we have previously shown that
CS causes a transient decrease in epithelial barrier func-
tion (Amatngalim et al. 2015). However, in contrast to
Heijink et al., we did not observe differences between
COPD and non-COPD cultures at baseline conditions
and upon CS exposure (G.D. Amatngalim et al., unpubl.
data), which may be explained by the fact that Heijink
et al. focused on severe (GOLD stage IV) COPD. Another
explanation might be differences in epithelial cell differen-
tiation, as it has been shown that COPD epithelial cells
display a more mesenchymal phenotype due to enhanced
autocrine expression of TGF-b1 (Gohy et al. 2015).
As previously shown, the EGFR-ADAM17 pathway is
essential for IL-8 release from a bronchial epithelial cell
line exposed to particulate air pollution (Ovrevik et al.
2011) and implicated in CS extract-induced expression of
the mucin MUC5AC (Shao 2004). Further, autocrine pro-
duction of EGFR ligands is involved in CS-induced IL-8
release from airway epithelial cells (Richter et al. 2002).
Our studies extend these observations by showing the
involvement of the ADAM17-EGFR pathway in the
release of IL6R and AREG upon CS exposure of differen-
tiated PBEC, both in the presence (Fig. 4), and absence
(Fig. 6) of EGFR ligand (EGF) in the basal medium
respectively. Notably, the basal shedding rates are consid-
erably lower in cells preincubated in medium lacking
EGF, resulting in a much larger ADAM17- and EGFR-
dependent stimulation effect of CS (compare Figs 4 and
6). Which of these extreme conditions of basal EGFR
activation apply in normal and COPD lungs in situ, and
to what extent autocrine feedback signaling through
ADAM-dependent EGFR ligand shedding determines
EGFR activity (Fig. 8) remains to be established.
Additionally, EGFR and ADAM17 were both essential
for CS-induced IL6R and AREG mRNA expression
(Fig. 7). These results provide novel insights into the
mechanisms of airway epithelial cell activation by cigar-
ette smoke in COPD, and highlight a role of ADAMs and
EGFR in this process (Fig. 8).
We further found that CS increases shedding of IL6R
and AREG to the basal medium, but not to the apical
side (Fig. 1). This is in line with report in polarized
Madin-Darby canine kidney cells (MDCK cells) showing
that newly synthetized AREG is directly delivered to the
basolateral surface with >95% efficiency (Brown et al.
2001). However, this is in contrast to the secretion of the
innate immune mediators IL-8 and ribonuclease 7, which
were also detected at the apical surface (Amatngalim et al.
2015). A polarized ADAM17-mediated secretion toward
underlying tissue may be relevant for lung tissue remodel-
ing through autocrine, paracrine, extracrine (exosomal
targeted receptor activation) pathways in COPD (Booth
et al. 2007; Zhou et al. 2012). Further examination of this
phenomenon in epithelial–mesenchymal co-culture sys-
tems is in progress.
Amphiregulin release and phosphorylation of ADAM17
after CS extract treatment in ALI-PBEC has been previ-
ously detected by ELISA or western Blotting (Lemjabbar-
Alaoui et al. 2011). Our proximity ligation assay (PLA)
2016 | Vol. 4 | Iss. 16 | e12878
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data show for the first time that CS-induced shed-
ding involves an intracellular interaction between
phosphorylated ADAM17 and its substrates (Figs 5 and
8), whereas the majority of the literature suggests that
shedding occurs mainly at the plasma membrane surface.
This interaction likely takes place in intracellular
ADAM17
Full-IL6R                sIL6R
IL6
Full-AREG               AREG
gp130 in complex 
with IL6R and IL6
EGFR EGFR-P
• Inﬂammaon  
P-STAT3
Transacvaon
Autocrine acvaon
STAT3
P-STAT3
IL6R AREG 
IL8 mRNA
• Tissue remodeling
1. Air: basal acvity 2. CS: acvaon 3. Secreon/transacvaon
Cigaree smoke exposure
Figure 8. Cigarette smoke exposure activates EGFR-ADAM17 axis in airway epithelial cells. Under basal conditions, there is ADAM17 related
AREG and IL6R shedding activity, depending on the level of EGFR activity (compare Figs 4 and 6). Cigarette smoke exposure (CS) initiates an
interaction of the phosphorylated form of ADAM17 (ADAM17-P) with the full-length transmembrane forms of IL6R and AREG in an
intracellular compartment of the airway epithelial cell (Fig. 5), resulting in proteolysis and subsequent secretion (shedding) of the soluble active
domains of IL6R and AREG toward the basolateral compartment. This involves both ADAM17 and EGFR activity (Figs 4 and 6). CS exposure
also affects IL6R and AREG gene expression or mRNA stabilization in airway epithelial cells through ADAM17 and EGFR activation. sAREG and
sIL6R secreted towards the basolateral compartment may change the level of activity of EGFR and the interleukin receptor IL6st/gp130 on the
airway epithelial cells (autocrine). This may contribute to the activity of the EGFR/ADAM17 axis (positive feedback), which is likely kept in check
by inactivation of internalized EGFR. Paracrine activity of sAREG and sIL6R may further transactivate EGFR and the interleukin receptor IL6st/
gp130 on the underlying myofibroblasts, and myeloid cells, activating downstream pathways, including STAT3, involved in inflammation,
collagen deposition, and myofibroblast proliferation.
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membranes that sequester active phosphorylated
ADAM17 and its transmembrane substrates upon activa-
tion. This process may relate to the transient change in
barrier function upon CS treatment in our system and
the subsequent activation of EGFR (Amatngalim et al.
2015). Our observation is supported by other reports
showing the presence ADAM17 or its substrates in a
vesicular compartment in lysosomes (Ebsen et al. 2015),
endosomes (Gephart et al. 2011; Dombernowsky et al.
2015), and exosomes negative for the ER marker calretic-
ulin (Higginbotham et al. 2011). Moreover, Gutwein et al.
demonstrated that ADAM10-mediated L1 migration fac-
tor cleavage occurs in Golgi-derived vesicles in tumor
cells (Gutwein et al. 2002). This was further supported by
a recent paper suggesting that also ADAM10/ADAM17-
mediated release of soluble FasL occurs from an intracel-
lular vesicular pool of secretory lysosomes in stimulated T
lymphocytes (Ebsen et al. 2015).
Moreover, after ligand binding, EGFR traffics in endo-
somes from the plasma membrane to an intracellular
compartment to continue its signaling (Vieira et al. 1996;
Teis et al. 2006). EGF-dependent MAPK signaling occurs
from late endosomes and lysosomes (de Araujo et al.
2013). Interestingly, the MAPK/ERK pathway regulates
trafficking of ADAM17 phosphorylated at Thr735 from
the endoplasmic reticulum toward the plasma membrane
(Soond 2005; Hilliard et al. 2011), which can be also acti-
vated through ligand binding to EGFR. Higginbotham
et al. showed that AREG containing exosomes are rapidly
internalized by recipient cells in an EGFR-dependent
manner (Higginbotham et al. 2011), enhancing invasion
of LM2-4175 cells through Matrigel and wound healing.
In our ALI-PBEC system, we observed a predominantly
lateral localization of EGFR under basal culture condi-
tions. After exposure to CS, we observed a more cytoplas-
mic localization, consistent with EGFR activation
(Figure S2). Therefore, in line with these and published
observations, our findings suggest that in HBEC-ALI, CS
triggers EGFR-mediated trafficking of ADAM17 and its
substrates to a common subcellular compartment to allow
proteolysis and subsequent secretion of soluble products
(Fig. 8). At this time, we cannot establish to what extent
autocrine signaling through shed ADAM substrates deter-
mine this response, or whether alternative mechanisms
such as transactivation by intracellular kinases or oxida-
tion or the extracellular receptor domain plays a role.
Additional studies of triggered trafficking of EGFR,
ADAM17-P, and its substrates in polarized airway cells
are required to further establish this mechanism.
In addition to CS-enhanced release through ADAM17
enzymatic activity, we observed transiently enhanced
mRNA expression of both AREG and full-IL6R in ALI-
PBEC upon CS exposure (Figure 3). CS did not affect
the level of the alternatively spliced form of IL6R, so we
conclude that alternative splicing unlikely contributes to
CS-enhanced release of IL6R. Previously, we observed
upregulated IL-8 mRNA expression in ALI-PBEC
exposed to CS as a result of enhanced EGFR phosphory-
lation and activation of the downstream MAPK/ERK1/2
signaling pathway (Amatngalim et al. 2015). Here, we
report that CS-induced IL6R and AREG mRNA expres-
sion was also reduced upon EGFR inhibition. In addi-
tion, we show here for the first time that inhibition of
ADAM17 has the same effect on these mRNA levels
(Fig. 7). Therefore, our data suggest that CS enhances
factors common for activation of IL6R, AREG, and IL-8
mRNA expression likely via an autocrine ADAM17-
EGFR axis (Fig. 8).
The transcriptional and posttranscriptional regulation
of these genes upon inhaled toxic substances has not
been fully elucidated. Induced EGFR signaling is able to
activate transcription of target genes. In addition, it has
been shown that CS extract enhances HuR-mediated IL-
8 mRNA stability in airway epithelial cells (Hudy and
Proud 2013). Moreover, UV-exposure of keratinocytes
enhances mRNA HuR-mediated stability of AREG, in an
EGFR-dependent manner (Nakayama et al. 2013). These
observations suggest that CS-induced activation of EGFR
enhances sIL6R, AREG, and IL8 mRNA stability in ALI-
PBEC. Furthermore, mRNA regulation may be altered in
cultured airway epithelial cells from COPD patients
(Steiling et al. 2013). CS-treated COPD ALI-PBEC
expressed lower AREG and IL6R mRNA levels on aver-
age compared to non-COPD controls, but this difference
was not statistically different (Fig. 3). Further studies on
mRNA stability in this system are required to establish
this. Nevertheless, this observation contrasts with the
shedding data (Fig. 2) and suggests that ADAM17-
dependent AREG and sIL6R output is not primarily reg-
ulated on the mRNA level, but involves posttranslational
regulation.
Our data support the relevance of the ADAM17/EGFR
pathway in COPD development and progression. Selective
inhibitors of ADAM17, EGFR, and other components of
this signaling pathway such as JAK and MAPK potentially
expand therapeutic possibilities. The development of
ADAM inhibitors for clinical use has been studied inten-
sively (Moss et al. 2008; Duffy et al. 2011; Dreymueller
et al. 2015). In cellular and animal tumor models, positive
results were recorded (Witters et al. 2008). An ADAM17
inhibitor, TAPI-0, reduced bleomycin-induced lung
inflammation (Lee et al. 2012). The selective inhibitor
TMI-2 used in this study, reduced LPS-induced inflamma-
tion in vivo (Zhang et al. 2004). However, due to a lack of
target specificity of available compounds, and side effects
associated with the various other biological functions of
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ADAMs, chronic and systemic application of these com-
pounds in humans is so far prohibited (Arribas and Esse-
lens 2009). Clearly, more advanced intervention tools are
required. Our data offer new insights in the regulation of
mRNA expression, secretion, and release of ADAM17 sub-
strates in airway epithelial cells upon triggering, which in
combination with state of the art molecular design and
advanced organotypic cellular modeling of airways could
allow development of more selective inhibitors, targeted to
specific cells and subcellular domains.
In summary, this study provides evidence that
ADAM17-mediated release and shedding of IL-6R and
AREG is highly enhanced in airway epithelial cells in
response to CS-induced injury. Next to ADAM17, we
highlight the importance of EGFR in the regulation of
IL6R and AREG release and mRNA expression. Moreover,
CS-induced ADAM17-mediated shedding of IL6R and
AREG is especially high in COPD ALI-PBEC, suggesting
that reducing ADAM17 activity in COPD might be a
potential therapeutic approach.
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Figure S1. The proximity ligation assay (PLA) back-
ground signal.
Figure S2. Lateral EGFR in ALI-PBEC, internalized after
CS treatment. ALI-PBEC cultured under basal conditions,
including (EGF and PBE) were treated with air or CS as
described in the methods section. (A) lateral EGFR
immune fluorescence signal (green) becomes more diffuse
3 h after CS treatment. (B) Lateral E-cadherin (red) illus-
trates the partial cytoplasmic localisation of EGFR. (C)
This is confirmed in a separate experiment, after 10 min
exposure to air or CS, with three separate filters each.
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